Johnson & Johnson (JNJ)
NYSE: JNJ · Real-Time Price · USD
164.64
-0.18 (-0.11%)
Sep 12, 2024, 4:00 PM EDT - Market closed
Stock Price Forecast
The 12 analysts with 12-month price forecasts for Johnson & Johnson stock have an average target of 172.42, with a low estimate of 150 and a high estimate of 215. The average target predicts an increase of 4.73% from the current stock price of 164.64.
Analyst Consensus: Buy
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | $150 | $172.42 | $170 | $215 |
| Change | -8.89% | +4.73% | +3.26% | +30.59% |
Analyst Ratings
The average analyst rating for JNJ stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '24 | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 2 | 3 | 3 | 3 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 7 | 7 | 7 | 7 | 6 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 12 | 13 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $215 | Buy | Reiterates | $215 | +30.59% | Sep 9, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $215 | Buy | Reiterates | $215 | +30.59% | Sep 3, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $215 | Buy | Reiterates | $215 | +30.59% | Aug 5, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $215 | Buy | Reiterates | $215 | +30.59% | Jul 30, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $175 | Buy | Reiterates | $175 | +6.29% | Jul 30, 2024 |
Financial Forecast
Revenue This Year
89.14B
from 85.16B
Increased by 4.67%
from 85.16B
Revenue Next Year
92.01B
from 89.14B
Increased by 3.22%
from 89.14B
EPS This Year
10.13
from 13.72
Decreased by -26.20%
from 13.72
EPS Next Year
10.82
from 10.13
Increased by 6.87%
from 10.13
| Fiscal Year | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Dec 29, 2019 | Jan 3, 2021 | Jan 2, 2022 | Jan 1, 2023 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 | Dec 31, 2026 | ||
| Revenue | 82.06B | 82.58B | 78.74B | 79.99B | 85.16B | 89.14B | 92.01B | 95.27B | ||
| Revenue Growth | 0.59% | 0.64% | -4.65% | 1.59% | 6.46% | 4.67% | 3.22% | 3.55% | ||
| EPS | 5.63 | 5.51 | 7.81 | 6.73 | 13.72 | 10.13 | 10.82 | 11.35 | ||
| EPS Growth | 0.36% | -2.13% | 41.76% | -13.84% | 103.94% | -26.20% | 6.87% | 4.82% | ||
| Forward PE | - | - | - | - | - | 16.25 | 15.21 | 14.51 | ||
| No. Analysts | - | - | - | - | - | 25 | 25 | 21 |
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 93.5B | 96.7B | 101.7B | ||
| Avg | 89.1B | 92.0B | 95.3B | ||
| Low | 82.3B | 88.3B | 90.5B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 9.8% | 8.5% | 10.5% | ||
| Avg | 4.7% | 3.2% | 3.5% | ||
| Low | -3.3% | -0.9% | -1.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 10.62 | 12.12 | 12.78 | ||
| Avg | 10.13 | 10.82 | 11.35 | ||
| Low | 9.77 | 9.96 | 9.93 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -22.7% | 19.6% | 18.0% | ||
| Avg | -26.2% | 6.9% | 4.8% | ||
| Low | -28.8% | -1.7% | -8.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.
